Gatralimab
Based on 1 publication(s) in Google Scholar
Gatralimab (GZ-402668) is an IgG1 anti-CD52 monoclonal antibody.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit : 97.94%
- CAS. Nr.: 1826020-80-7
- Molecular Weight:145 kDa
-
Speicherung:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
IC50 & Target
CD52
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
Anwendung
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized CD52 Protein, Human (His, HY-P72123) can bind Gatralimab. The EC50 for this effect is 13.12 ng/mL.
Product Details
-
CAS. Nr. 1826020-80-7
-
Accession P31358
-
Synonyms GZ-402668
-
Molecular Weight 145 kDa
-
Species Reactivity
Human
-
Conjugated
Unconjugated
-
Isotype
Human IgG1 kappa
-
Recommend Isotype Controls
-
Format
-
Human IgG1 kappa
-
Product Properties
-
Appearance
Liquid
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Reinheit
97.94%
-
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
-
Storage & Stability
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Versand
Shipping with dry ice.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
NPJ Breast Cancer
CD52 signaling via macrophage Siglec-G represents a therapeutic target for cancer immunotherapy. [Abstract]2026 Jan 24;12(1):29. PMID: 41580422
Reinheit & Dokumentation
-
Data Sheet (256 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)